BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 17927847)

  • 21. Long-term survival of women with locally advanced breast cancer with ≥ 10 involved lymph nodes at diagnosis.
    Zeichner SB; Cavalcante L; Suciu GP; Ruiz AL; Hirzel A; Krill-Jackson E
    Asian Pac J Cancer Prev; 2014; 15(8):3435-41. PubMed ID: 24870735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer.
    Berclaz G; Altermatt HJ; Rohrbach V; Siragusa A; Dreher E; Smith PD
    Int J Oncol; 2001 Dec; 19(6):1155-60. PubMed ID: 11713584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heat shock protein 27 and gross cystic disease fluid protein 15 play critical roles in molecular apocrine breast cancer.
    Liu X; Feng C; Liu J; Zhao L; Liu J; Zhang W; Liu N; Niu Y
    Tumour Biol; 2016 Jun; 37(6):8027-36. PubMed ID: 26711786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
    Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
    Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
    El-Gendi SM; Mostafa MF
    Pathol Oncol Res; 2016 Jul; 22(3):461-70. PubMed ID: 26597806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
    Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
    Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.
    Lee BL; Lee HS; Jung J; Cho SJ; Chung HY; Kim WH; Jin YW; Kim CS; Nam SY
    Clin Cancer Res; 2005 Apr; 11(7):2518-25. PubMed ID: 15814628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
    Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
    Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
    Yanai A; Inoue N; Yagi T; Nishimukai A; Miyagawa Y; Murase K; Imamura M; Enomoto Y; Takatsuka Y; Watanabe T; Hirota S; Sasa M; Katagiri T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):197-203. PubMed ID: 25600244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of PTEN, p53 and EGFR in the molecular subtypes of breast carcinoma and 
the correlation among them].
    Li X; Wang Q; Fu L; Liu M; Yu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 40(9):973-8. PubMed ID: 26408616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
    Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
    Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone receptors and HER2 expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both?
    Raica M; Cîmpean AM; Ceausu RA; Fulga V; Nica C; Rudico L; Saptefrati L
    Anticancer Res; 2014 Mar; 34(3):1435-40. PubMed ID: 24596391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis.
    Albasri A; Aleskandarany M; Benhasouna A; Powe DG; Ellis IO; Ilyas M; Green AR
    Breast Cancer Res Treat; 2011 Feb; 126(1):47-54. PubMed ID: 20390342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
    Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of phosphorylated STAT-1 expression in premenopausal and postmenopausal patients with invasive breast cancer.
    Magkou C; Giannopoulou I; Theohari I; Fytou A; Rafailidis P; Nomikos A; Papadimitriou C; Nakopoulou L
    Histopathology; 2012 Jun; 60(7):1125-32. PubMed ID: 22320867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer.
    Park MH; Kwon HJ; Kim JR; Lee B; Lee SJ; Bae YK
    Ann Surg Oncol; 2017 Nov; 24(12):3780-3787. PubMed ID: 28634667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Br J Cancer; 2007 Sep; 97(5):659-69. PubMed ID: 17700572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression.
    Balduzzi A; Bagnardi V; Rotmensz N; Dellapasqua S; Montagna E; Cardillo A; Viale G; Veronesi P; Intra M; Luini A; Pruneri G; Mastropasqua G; Goldhirsch A; Colleoni M
    Clin Breast Cancer; 2014 Aug; 14(4):258-64. PubMed ID: 24325948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.